NCT04959175

Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies

RecruitingPHASE1, PHASE2INTERVENTIONAL

Trial Details

Start: 2021-09-23Est. Completion: 2027-04-27

Enrollment target: 320 participants

Locations

National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Contact

Amy H Chaiamy.chai@nih.gov (240) 858-3755

Christopher G Kanakry, M.D.christopher.kanakry@nih.gov (240) 760-6171

Other microbiome trials you might be interested in

A Study of Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic LeukemiaPhase 1Recruiting

Relapsed Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaB-cell Acute Lymphoblastic LeukemiaPediatric CancerPediatric ALL, RelapsedPediatric ALLPediatric ALL, B CellAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaPediatric AMLR/R AMLR/R B-cell ALL

The goal of this clinical trial is to learn if sonrotoclax (BGB-11417) is safe and may help treat children and adolescen…

Multiple LocationsEst. completion Apr 30, 2030

View Trial →

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.